Since 1996 WHN is the second oldest medical website on the net, second only to the American Medical Association, servicing over 35,000 physicians and scientists worldwide.

Non-Profit Trusted Source of Non-Commercial Health Information

Stem Cells for Low Back Pain

Emory University (US) researchers reduce discogenic low back pain via a single injection of stem cells into degenerative discs.

Discogenic low back pain, a painful degenerative disc, is the most common cause of chronic low back pain.   W. Jeremy Beckworth, from Emory University (Georgia, USA), and colleagues completed a 100-patient, phase II, international clinical trial that administered injections of bone marrow stem cells known as mesenchymal precursor cells (MPCs) to reduce pain, among patients with moderate to severe discogenic low back pain.  A single injection of stem cells into degenerative discs reduced low back pain by as much as 50%, for at least 12 months.  Additionally, there was less need for pain medication, improvement in function, and less need for further surgical and non-surgical spine interventions.

“Safety and Preliminary Efficacy Study of Mesenchymal Precursor Cells (MPCs) in Subjects With Lumbar Back Pain,” NCT01290367.